logo

ATYR

aTyr Pharma·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

ATYR fundamentals

aTyr Pharma (ATYR) released its earnings on Aug 7, 2025: revenue was 0 (YoY 0.00%), beat estimates; EPS was -0.22 (YoY +4.35%), missed estimates.
Revenue / YoY
0
0.00%
EPS / YoY
-0.22
+4.35%
Report date
Aug 7, 2025
Earnings Call
7:00 AM on Aug 7, 2025
Meeting link.
EPS
Revenue

Revenue & Expenses

ATYR has released its 2025 Q3 earnings report, with revenue of 190.00K, reflecting a YoY change of NaN%, and net profit of -25.75M, showing a YoY change of -49.16%. The Sankey diagram below clearly presents ATYR's revenue sources and cost distribution.

Key Indicators

aTyr Pharma (ATYR) key financial stats and ratios, covering profitability, financial health, and leverage.
aTyr Pharma (ATYR)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
aTyr Pharma (ATYR)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
aTyr Pharma (ATYR)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does aTyr Pharma (ATYR) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track aTyr Pharma (ATYR) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield